In less than 10 years since its inception, RNA interference (RNAi) has had extraordinary impact on biomedical science. RNAi has been demonstrated to influence numerous biological and disease pathways. Development and adoption of RNAi technologies have been prolific ranging from basic loss-of-function tools, genome-wide screening libraries to pharmaceutical target validation and therapeutic development. However, understanding of the molecular mechanisms of RNAi is far from complete. The purpose of this brief review is to highlight key achievements in elucidating the biochemical mechanisms of the RNA-induced silencing complex and to outline major challenges for the field.
Introduction
The phenomenon of RNA-induced silencing was first documented in plants by Jorgensen and co-workers [1] . The field of RNA interference (RNAi) was initiated from studies conducted by Fire, Mello and co-workers [2] , who induced silencing of endogenous and reporter genes in Caenorhabditis elegans following injection of long double-stranded RNA (dsRNA). Hamilton and Baulcombe [3] discovered a class of small RNA species mediating post-transcriptional silencing in plants. A seminal biochemical advance was made by Zamore et al. [4] who recapitulated dsRNA-induced silencing in vitro using Drosophila melanogaster embryo lysates. Demonstration of dsRNA-induced silencing in Drosophila S2 cells by Hannon and co-workers established a source of material amenable to biochemical purification [5] . Purification of mRNA cleavage activity from dsRNAtreated S2 cells revealed a ribonucleoprotein complex comprising a nuclease and small RNA. This complex was named RNA-induced silencing complex (RISC) [5] . The location at which target mRNA was cleaved corresponded to the small ~21-23-nucleotide duplex products derived from longer dsRNA-silencing triggers [3, 6] .
Small-interfering RNA
Tuschl and co-workers [7] hypothesized that these smaller RNA species directed the activity of the RISC complex. Indeed, chemically synthesized 21mer duplexes were found to trigger the cleavage of complementary mRNA in Drosophila extract [7] . Perhaps the most important technological advance in the field came when Tuschl and co-workers [8] demonstrated that synthetic 21mer duplex RNA could be transfected into human cells and knockdown target expression. Further work established 21-nucleotide duplex RNA with two nucleotide 3′ overhangs as the standard small-interfering RNA (siRNA) [9] . Thus, siRNA carries sequence information directing the activity of the RISC complex to specific target transcripts.
microRNA
The discovery of siRNA catalyzed our understanding of a related and previously known small RNA-mediated regulatory mechanism. The lin-4 locus encoding a 22-nucleotide non-coding RNA was identified as a temporal regulator of the lin-14 transcriptional unit [10, 11] . Similarly, a 21-nucleotide let-7 RNA was found to govern the expression of a number of genes in the heterochronic lin family [12] . The emergence of siRNA ushered in new methodologies for bioinformatic prediction and cloning of these endogenous microRNAs (miRNAs). It is believed npg Cell Research | www.cell-research.com Biochemical mechanisms of RISC that miRNAs are global regulators of gene expression involved in numerous developmental and physiological processes [13] . The siRNA and miRNA pathways share many similarities including their biogenesis and silencing effects on target expression.
Dicer
The discovery of siRNA in directing RNAi intensified the search for factors that generate these small RNA species. Based on the physical properties of the siRNA duplex, Hannon and co-workers [14] deduced that members of the RNase III family were likely candidates responsible for generating siRNAs. Using expression constructs encoding epitope-tagged members of the RNase III family, analyses of immunoprecipitated material from Drosophila S2 cells revealed that long dsRNA processing was specifically attributed to an unknown protein, CG4792, which was then termed Dicer-1 [14] . Biochemical purification of siRNA-generating activity to homogeneity from S2 extract revealed an unknown protein CG6493, which was named Dicer-2 [15] . Thus, the Drosophila genome encodes two Dicer enzymes.
Analysis of the let-7 miRNA transcript predicted a possible hairpin-like secondary structure [16] . Hutvagner et al. [17] demonstrated the existence of such a precursor in pupae stage Drosophila as well as in HeLa cells. Further, in vitro-transcribed let-7 precursor was processed to 22-nucleotide products in the Drosophila embryo extract. The double-stranded nature of let-7 precursor and the chemical similarities between siRNA and the let-7 miRNA raised the possibility that Dicer could generate both siRNA and miRNA. Indeed, siRNA-mediated knockdown of human Dicer in HeLa cells resulted in the attenuated production of let-7 and the accumulation of its precursor [17] .
Using genetically mutated alleles in Drosophila, Lee et al. [18] identified distinct functions for Dicer-1 and Dicer-2. Dicer-1 was required for processing precursor miRNA (pre-miRNA) to miRNA, and Dicer-2 was needed for the conversion of long dsRNA to siRNA [18, 19] . Recombinant Drosophila Dicer-1 was found to preferentially process pre-miRNA, and Dicer-2 preferentially processed long dsRNA [20] .
In contrast, the human genome encodes only one Dicer enzyme. Hutvagner et al. [17] identified the human homolog of Drosophila Dicer by using sequence homology and siRNA-mediated knockdown. Depletion of human Dicer resulted in the attenuated production of let-7 and the accumulation of its precursor [17] . These findings indicated that human Dicer catalyzes the conversion of precursor miRNA to mature miRNA. Zhang et al. [21] established that recombinant human Dicer could generate both siRNA and miRNA.
Argonaute
Although Dicer was determined as the initiator nuclease of RNAi, effector components in the RISC complex remained to be identified. As in vitro RISC activity is salt sensitive, biochemical purification of the RISC complex from naïve cells is not possible (Figure 1 ). However, RISC complexes that are loaded with siRNA are highly resistant to salt. This can be achieved by treating cells with dsRNA. Although the biochemical basis for this marked difference is not known, (Box 1) pre-treatment of cells with dsRNA has been exploited to identify the effector machinery. The first biochemical evidence for the involvement of Argonaute (Ago) proteins in RISC came from a five-column purification of pre-loaded RISC activity to near homogeneity using long dsRNA-treated Drosophila S2 cells [22] . Mass spectrometry analysis revealed a previously unidentified protein CG7439, which was named Ago2. Immunoblot analysis indicated perfect correlation between RISC activity and Ago2. Using a similar strategy, Rand et al. [23] purified pre-loaded RISC activity to near homogeneity and identified Drosophila Ago2 and siRNA as the core components of RISC.
Although preceding genetic studies established the involvement of Ago proteins in RNAi [24, 25] , these biochemical achievements indicated a functional role for Ago. Demonstration of an Ago protein as a catalytic component of RISC came from affinity purification of Ago proteins from human cells. Affinity purification of biotinylated siR- Figure 1 In vitro RISC activity is not recovered following anionexchange column chromatography. Naïve Drosophila S2-S100 extract was loaded on to a HiTrap Q column and eluted with up to 1 M NaCl. Assays were performed using 100 nM duplex siRNA and 32 P-labeled in vitro transcribed target mRNA and incubated at 30 °C for 30 min. Input material demonstrated high activity as most of the full-length target mRNA was cleaved. No activity is observed for flow through (FT) or bound fractions. Combining flow through and bound fractions (All) did not reconstitute activity. npg NA from HeLa cell extract identified eIF2C proteins, which represent Drosophila Ago2 homologs, as components of RISC [26] . Immunoprecipitated myc-tagged mammalian Ago2 cleaved target mRNA while Ago1 and Ago3 did not [27] . A similar approach using S2 cells indicated that Drosophila Ago1 and Ago2 could cleave complementary mRNA [28] . Deletion and mutation analysis of epitopetagged human Ago2 revealed specific residues comprising the catalytic site [27] . This finding, in combination with crystal structures of Ago from Pyrococcus furiosus and Aquifex aeolicus, revealed a conserved aspartate-aspartatehistidine RNaseH-like active site in the PIWI domain of Ago2 [29] [30] [31] . Direct demonstration of Ago2 as the slicer of RISC was achieved by the reconstitution of a "minimal RISC" [30] . Recombinant human Ago2 generated from bacteria and single-strand siRNA were sufficient to catalyze the sequence-specific cleavage of target RNA. Recombinant Ago2-bearing alanine mutations in the putative active site abolished this activity. Importantly, recombinant Ago2 was not sufficient in directing duplex siRNA-mediated target cleavage [30] .
dsRNA-binding proteins
RNAi is initiated by the Dicer-mediated processing of long dsRNA to siRNA duplexes. siRNA is then assembled on to the effector RISC complex to direct the sequencespecific cleavage of target mRNA. However, it was unclear as to how the initiation and effector steps were connected. A novel component of the RNAi pathway was revealed following chromatographic purification of siRNA-generating activity to homogeneity from Drosophila S2 extract [15] . Mass spectrometry revealed Dicer-2 and a previously unidentified protein CG7138. This protein was named R2D2 because of its two dsRNA-binding domains (R2) and association with Dicer-2 (D2). The role of R2D2 was revealed in a partially reconstituted RISC system. Recombinant Dicer-2, Dicer-2/R2D2 or Dicer-2/mutant R2D2 were added to partially purified RISC fractions to reconstitute dsRNA-or siRNA-initiated RISC. Recombinant Dicer-2/ R2D2 produced much higher RISC activity than Dicer-2 alone or Dicer-2/mutant R2D2 [15] . These findings were supported by genetic studies employing extract from R2D2 null flies that were fully competent for siRNA production but markedly defective for RISC activity [32] . Recombinant R2D2 fully rescued this defect, possibly by bridging the initiation and effector complexes.
The discovery of a dsRNA-binding protein (dsRBP) partner for Dicer-2 raised the possibility of such a cofactor for Dicer-1. Sequence alignment and biochemical purification of miRNA-generating activity revealed a novel protein R3D1 [20, 33, 34] . This nomenclature derives from its three dsRNA-binding domains (R3) and its association with Dicer-1 (D1). R3D1 is also known as loquacious as mutant flies were found to de-repress the expression of a miRNA-regulated reporter gene [33, 34] . Genetic mutation and RNAi knockdown of R3D1 resulted in defective pre-miRNA processing in vitro and accumulation of endogenous pre-miRNAs [20, 33, 34] . Recombinant R3D1 facilitated Dicer-1-mediated miRNA production, possibly by enhancing the affinity of Dicer-1 for its substrate premiRNAs [20] .
Domain homology search revealed two candidates as tandem partners for human Dicer. Transactivating response RNA-binding protein (TRBP) and protein activator of protein kinase R (PACT) each harbor three annotated dsRNA-binding domains and have been shown to interact with Dicer [35] [36] [37] . siRNA knockdown of TRBP resulted in diminished miRNA production and loss of reportergene silencing in HeLa cells [35, 36] . Similar results were observed in similar experiments targeting PACT [37] . However, the precise role of TRBP and PACT in mediating human RISC activity remains poorly understood.
dsRBPs are not known to have any intrinsic catalytic activity. However, dsRBP-mediated enhancement of Dicer activity [20] and their requirement in partially reconstituted RISC systems [15, 32] indicate that these components are important regulators of the catalytic RNAi machinery. 
RISC assembly and activation
A bi-phasic model for RISC function was now established [15, 19, 38] . Dicer and a dsRBP partner generate duplex siRNA and miRNA. Ago and single-strand RNA direct the silencing of target mRNAs [22] . However, it remains unknown how duplex siRNA are converted to single-strand guide RNA during RISC assembly (Box 1).
Using Drosophila embryo extracts, Nykanen et al. [39] observed the dissociation of radiolabeled duplex siRNA strands. The unwinding activity exhibited ATP dependency and eluted as a peak following gel filtration. This siRNA strand separation model was supported by observations made using biotinylated siRNA. Affinity purified human RISC complex contained only one siRNA strand [26] . These findings gave rise to an unwinding model of RISC activation possibly mediated through a helicase (Figure 2A) . Subsequent genetic analyses and co-immunoprecipitation studies have revealed several candidate helicases associated with known RISC components [38, 40, 41] . However, no helicase has been demonstrated to function directly in the activation of RISC.
siRNA incorporation into RISC can be asymmetric [42] . That is, one siRNA strand is preferentially loaded on to RISC. Computational analyses revealed that miRNA from human, mouse, fly and worm exhibited a defined thermodynamic signature [43] . The 5′ and median nucleotides of the incorporated miRNA strand had lower thermodynamic stability relative to other positions. This profile was also observed for functional but not non-functional siRNA.
A direct test for these rules was made by rescuing nonfunctional siRNA through introducing 5′ and internal mismatches [42, 43] . These findings indicate that RISC assembly is an asymmetric process.
Tomari et al. [44] initiated studies aimed at elucidating the interaction of Dicer-2 and R2D2 with siRNA. Crosslinking experiments indicated a possible role for R2D2 in sensing thermodynamic siRNA structure. R2D2 marked the more stable 5′ terminus excluding this siRNA strand from RISC. Subsequent studies revealed that this potential asymmetric sensing mechanism was possible for mature siRNA and for siRNA processed from long dsRNA precursors [45] . Using radiolabeled siRNA and native gel electrophoresis, Drosophila Dicer-2 and R2D2 were identified in an RISC loading complex required for the formation of RISC [19, 44] . These studies outline a role for Dicer and dsRBP in generating, loading and activating RISC in an asymmetric manner.
Slicer-mediated RISC activation
The slicer function of Ago has been proposed as an alternative mechanism in the process of RISC assembly. In contrast to siRNA strand separation models, the slicer model of RISC activation outlines the transfer of duplex siRNA from the RISC loading machinery to Ago2 [46, 47] . Duplex RNA loaded on Drosophila Ago2 is then acted upon as the guide and the target resulting in cleavage of the passenger strand ( Figure 2B ). Using radiolabeled passenger strand annealed to unlabeled guide strand, the predicted labeled npg 9mer passenger strand cleavage product was detected in Drosophila embryo lysates [28, 46, 47] . Further, no 9mer cleavage products were identified in extracts from ago2 null embryos [47] , nor from r2d2 or dicer-2 null embryos [46] . These experiments indicate the possibility of slicermediated activation of RISC. However, the generality of this mechanism of RISC activation is unclear. To date, among the four human Agos, cleavage activity has only been demonstrated for human Ago2, yet transfected siRNA has been shown to interact with all four human Ago proteins [48] . Moreover, duplexes bearing mismatches such as that of miRNA do not undergo passenger strand cleavage [46] . Thus, a cleavage model of RISC activation may not be all encompassing. It is possible that there are multiple mechanisms of RISC activation including those mediated through siRNA strand displacement and passenger strand cleavage. Clearly, the biochemical events that occur between the action of Dicer and formation of the active RISC complex are poorly understood and represent a long-standing challenge for the field (Box 1).
RISC effector mechanisms
The best understood mechanism by which RISC executes RNAi is Ago-mediated cleavage of target mRNA. Following siRNA administration to mice and using an RNA ligase and cDNA amplification protocol, Soutschek et al. [49] demonstrated the recovery of target mRNA cleaved at predicted sites.
One of the enduring dogmas in the field is the distinction between siRNA-induced RISC (siRISC) and that induced by miRNA (miRISC). Identification of two Dicers in Drosophila and their preferences for different substrates support the possibility of parallel pathways [18, 20] . Also, Drosophila Ago2 is required for siRISC and Ago1 is required for miRISC [50] . It has been suggested that guide RNA fully complementary to target mRNA induces siRISCmediated cleavage and partial complementarity results in miRISC-mediated translational repression [51, 52] .
It is worth clarifying that the net effect of RNAi is inhibition of target mRNA expression. Mechanisms by which this occurs can be classified as those that are dependent and those that are independent of Ago-mediated cleavage. However, the distinction between siRISC and miRISC may not be as simple as the parallel model predicts: (1) many species have only one Dicer; (2) human Dicer and Drosophila Dicer-1 can process both long dsRNA and premiRNA [20, 21] ; (3) although they are often distinguished by the degree of inter-strand complementarity, siRNA and miRNA share similar secondary structure, and algorithms used to design effective synthetic siRNAs are based on thermodynamic profiles of miRNAs [42, 43] ; (4) transfected siRNAs have been shown to load on to all four human Ago proteins [48] ; (5) siRNAs have been shown to cleave target mRNAs that are less than fully complementary [53] , and reporter constructs bearing imperfect let-7 target sites were found to be cleaved in human cells [54] ; (6) human miRNA-196 was found to cleave HOXB8 mRNA, an endogenous target transcript [55] ; (7) there is increasing evidence that miRNA reduces target mRNA levels [56, 57] . Thus, the degree of distinction and crosstalk among various RNAi pathways is not currently known. If RNAi is viewed as a genomic regulatory mechanism, then overlap of pathways and mechanistic redundancy would aid in functionality.
Understanding the cleavage-independent mechanisms of RNAi represent a large gap in the field (Box 1). A long-standing association between RNAi components and translational machinery suggests a connection between these two processes [58] . Co-immunoprecipitation and co-fractionation of polysomes with target mRNA and RISC components are most often used in such studies [59] . Various antibiotics and cap-dependent and cap-independent expression constructs have been employed to study miRISC-mediated inhibition of translation initiation [52] . A piwi protein was recently shown to interact with the mRNA cap-binding complex [60] . Further, the association between a factor involved in regulating mRNA stability and miRISC activity further indicate potential crosstalk between these cellular functions [61] . Coupling of RNAi with active translation would be an efficient means by which the RISC complex could survey transcriptome activity. However, as a minimal RISC complex, containing single-strand guide RNA and recombinant Ago is sufficient to effect target cleavage [30] ; the importance of protein synthesis in the recognition of mRNA by RISC is unclear (Box 1). Indeed, in vitro assays that mimic mechanisms of RISC function independent of transcript cleavage would be tremendously useful for the field.
A cellular mechanism for RISC has also emerged from findings of processing (P) bodies [62] . P-bodies are cytoplasmic foci containing RISC components and mRNA decapping and deadenylation factors [63] [64] [65] . A strong association has been shown for miRNA, target mRNA expression and P-body markers in human cells [61] . Stress granules are additional cellular structures that accumulate Ago proteins in a miRNA-dependent manner [66] . Support for these localization-mediated mechanisms of RNAi would be enhanced by elucidating how miRNA and their targets approximate in these regions and identifying factors that mediate these interactions.
Perspective
The central problem in understanding the biochemical npg Cell Research | www.cell-research.com Biochemical mechanisms of RISC mechanisms of RISC is an incomplete knowledge of the factors involved. Although genetic approaches have implicated a number of candidate factors, the precise role of these in effecting RNAi is unknown (Box 1). To date, Dicer, dsRBPs and Ago are the only RISC components that have been validated biochemically. Affinity-purified complexes from human cell extracts containing these three components can induce RISC activity in vitro [67, 68] . However, recombinant Dicer, dsRBPs and Ago are not sufficient to reconstitute RISC (Liu Q, unpublished) .
Creative and imaginative assays amenable to biochemical purification need to be developed to further advance the field (Box 1). The need for this is even more pressing in light of the new classes of small regulatory RNAs including piwi-interacting RNA (piRNA) [69, 70] and repeat-associated siRNA (rasiRNA) [71] . An example of the potential usefulness of alternative assays was demonstrated by Kingston and co-workers [72] who purified end-labeled piRNA from rat testis. Following five chromatograph column separations, piwi and RecQ1 were identified as a candidate effector complex for this class of small regulatory RNA [72] . As with siRISC and miRISC, elucidating biochemical mechanisms of small RNA biogenesis, complex assembly and function for these new pathways represent future challenges for the field.
Reconstituting the holo-RISC enzyme would be a benchmark achievement. That is, defining the RNAi machinery such that the activation and effector mechanisms of RISC are revealed would bring much needed mechanistic insight. Beyond this, however, understanding regulatory mechanisms that govern RNAi would connect the field to the wider biological context (Box 1). In principle, biochemical regulation of RNAi has been established [73] . The influence of cellular signaling pathways on RISC activity and the contribution of RNAi to physiological processes are critical in understanding the importance of small regulatory RNAs in biology and disease.
